Diabetes Centre, King Edward VII Hospital, Windsor, Berkshire, UK.
Oxford Brookes University, Oxford, UK.
J Appl Res Intellect Disabil. 2022 Nov;35(6):1253-1266. doi: 10.1111/jar.13027. Epub 2022 Aug 18.
People with intellectual disabilities are more likely to have diabetes and develop complications from it. Diabetes management is complex and insulin treatment in particular, people with intellectual disabilities may require additional support that is not always available. This review aimed to identify barriers and facilitators to managing diabetes with insulin in adults with intellectual disabilities.
Patient and public involvement (PPI) was integral to the development of the research question. A systemised review was conducted across CINAHL, the British Nursing Index and MEDLINE. PRISMA guidelines were followed. Narrative synthesis of the evidence was undertaken.
Barriers and facilitators to managing diabetes with insulin in people with intellectual disabilities were identified related to the individual, other people participating in their care, and broader environmental and social factors.
People with intellectual disabilities who use insulin, require reasonable adjustments to education, support, and a person-centred approach to facilitate supported self-management. More training for their supporters is needed and further inclusive research with PPI is recommended.
智障人士更有可能患有糖尿病，并由此产生并发症。糖尿病的管理非常复杂，尤其是胰岛素治疗，智障人士可能需要额外的支持，但这些支持并不总是能够提供。本综述旨在确定智障成年人使用胰岛素管理糖尿病的障碍和促进因素。
患者和公众参与（PPI）是制定研究问题的重要组成部分。对 CINAHL、英国护理索引和 MEDLINE 进行了系统的综述。遵循 PRISMA 指南。对证据进行了叙述性综合。
确定了智障人士使用胰岛素管理糖尿病的障碍和促进因素，这些因素与个人、参与他们护理的其他人以及更广泛的环境和社会因素有关。
使用胰岛素的智障人士需要对教育、支持和以患者为中心的方法进行合理调整，以促进其自我管理。需要为他们的支持者提供更多的培训，并建议进行更多的包容性研究，让患者参与其中。
